Medco Health Reaches New 52-Week High (MHS)

NEW YORK ( TheStreet) -- Medco Health Solutions (NYSE: MHS) hit a new 52-week high Friday as it is currently trading at $69.61, above its previous 52-week high of $69.10 with five million shares traded as of 12:50 p.m. ET. Average volume has been 3.3 million shares over the past 30 days.

Medco Health has a market cap of $24 billion and is part of the services sector and wholesale industry. Shares are up 21% year to date as of the close of trading on Thursday.

Medco Health Solutions, Inc., a healthcare company, provides clinically-driven pharmacy services for private and public employers, health plans, labor unions, government agencies, and individuals worldwide. The company has a P/E ratio of 18.5, above the average wholesale industry P/E ratio of 18.1 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Medco Health as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, growth in earnings per share, solid stock price performance and increase in net income. We feel these strengths outweigh the fact that the company has had generally poor debt management on most measures that we evaluated. You can view the full Medco Health Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.
null

If you liked this article you might like

Verizon & Vodafone Top the 5 Best M&A Deals of the Last 5 Years

Link: I'm a Buyer of Bristol Myers in Low $30s

Express Scripts and CVS = Real Winners in Walgreen Deal

CVS Has the Right Prescription

SXC Health Buys Catalyst for $4.4B as Pill Pushers Consolidate (Update 1)